CN102219752B - 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d - Google Patents
一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d Download PDFInfo
- Publication number
- CN102219752B CN102219752B CN 201110100792 CN201110100792A CN102219752B CN 102219752 B CN102219752 B CN 102219752B CN 201110100792 CN201110100792 CN 201110100792 CN 201110100792 A CN201110100792 A CN 201110100792A CN 102219752 B CN102219752 B CN 102219752B
- Authority
- CN
- China
- Prior art keywords
- triazole
- difluorobenzyl
- methane amide
- trifluoroacetic acid
- crystal formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
晶型A | 晶型B | 晶型C | 晶型D |
10.5 Å | 11.0 Å | 9.0 Å | 14.13 Å |
5.14 Å | 8.3 Å | 7.0 Å | 9.99 Å |
4.84 Å | 5.18 Å | 5.49 Å | 6.63 Å |
4.55 Å | 4.88 Å | 4.80 Å | 5.22 Å |
4.34 Å | 4.80 Å | 4.73 Å | 4.95 Å |
4.07 Å | 4.42 Å | 4.65 Å | 4.72 Å |
3.51 Å | 4.33 Å | 3.75 Å | 4.57 Å |
3.48 Å | 4.19 Å | 3.73 Å | 4.33 Å |
3.25 Å | 4.12 Å | 3.54 Å | 4.07 Å |
3.19 Å | 3.81 Å | 3.50 Å | 4.0 Å |
3.15 Å | 3.50 Å | 3.42 Å | 3.68 Å |
3.07 Å | 3.41 Å | 3.25 Å | 3.48 Å |
2.81 Å | 3.36 Å | 2.64 Å | 3.37 Å |
3.32 Å | 3.25 Å | ||
3.28 Å | 3.11 Å | ||
3.24 Å | 2.99 Å | ||
3.05 Å | 2.83 Å | ||
2.83 Å | 2.47 Å | ||
2.39 Å |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110100792 CN102219752B (zh) | 2011-04-21 | 2011-04-21 | 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110100792 CN102219752B (zh) | 2011-04-21 | 2011-04-21 | 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102219752A CN102219752A (zh) | 2011-10-19 |
CN102219752B true CN102219752B (zh) | 2013-04-10 |
Family
ID=44776482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110100792 Expired - Fee Related CN102219752B (zh) | 2011-04-21 | 2011-04-21 | 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102219752B (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4789680A (en) * | 1982-12-23 | 1988-12-06 | Ciba-Geigy Corporation | Aralkyltriazole compounds |
CA2260065C (en) * | 1996-07-11 | 2006-10-17 | Novartis Ag | Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
JP2012505191A (ja) * | 2008-10-13 | 2012-03-01 | シプラ・リミテッド | ルフィナマイドの製造方法 |
CN101768124B (zh) * | 2008-12-30 | 2012-01-04 | 北京本草天源药物研究院 | 一种药物晶体及其制备方法和用途 |
US8198459B2 (en) * | 2009-03-16 | 2012-06-12 | Dipharma Francis S.R.L. | Method for the preparation of rufinamide |
IT1395736B1 (it) * | 2009-08-04 | 2012-10-19 | Dipharma Francis Srl | Forme cristalline di rufinamide |
-
2011
- 2011-04-21 CN CN 201110100792 patent/CN102219752B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102219752A (zh) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6211072B2 (ja) | ダサチニブと、選択された共結晶形成剤とを含んでなる多成分結晶 | |
WO2011095059A1 (zh) | 达沙替尼多晶型物及其制备方法和药物组合物 | |
CN106661015B (zh) | 达沙替尼盐 | |
CN112142679B (zh) | 一种吉非替尼与香草酸共晶甲醇溶剂合物及其制备方法 | |
JP2016509031A (ja) | トレラグリプチンの固形形式及びその製造方法と用途 | |
JP2011503185A (ja) | ヘミフマル酸アリスキレンの多形形態及びその調製プロセス | |
WO2015126995A1 (en) | Solid state forms of sofosbuvir | |
TW200530186A (en) | Crystal form of quinoline compound and process for its production | |
EP3135666B1 (en) | (s)-oxiracetam crystal form iii, preparation method therefor, and application thereof | |
US20110269838A1 (en) | Novel processes and pure polymorphs | |
EP3476835A1 (en) | Crystal of quinoline derivative | |
CN102036948A (zh) | 阿利吉仑单富马酸盐及其制备方法 | |
EP2714683A2 (en) | Amorphous ritonavir co-precipitated | |
CN102219752B (zh) | 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d | |
US20080234286A1 (en) | Stable amorphous imatinib mesylate and production process therefor | |
US20080255231A1 (en) | Polymorphs of rivastigmine hydrogentartrate | |
US8754129B2 (en) | Crystalline vorinostat form VI | |
WO2010089753A2 (en) | Novel polymorphs of lopinavir | |
CN104829530A (zh) | 一种无定型盐酸伊伐布雷定及其制备方法 | |
CN105461618B (zh) | 甲磺酸洛美他派新晶型及其制备方法 | |
US20110165202A1 (en) | Solid state forms of fosamprenavir calcium salt and processes for preparation thereof | |
US7649008B2 (en) | Crystal of benzimidazole derivative and process for producing the same | |
EP3004104A1 (en) | Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1 h-pyrazol-3-ylamino)-6-ethyl-1 -methyl-1,6-dihyrdroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders | |
CN104513201B (zh) | 马来酸匹杉琼的结晶 | |
WO2017029408A1 (en) | Solid state forms of sofosbuvir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 100021 Beijing city Chaoyang District West business center boziwan Jinhai rich 402 (A) 21 storey building Applicant after: China Resources Saike Pharmaceutical Co., Ltd. Address before: 100021 Beijing city Chaoyang District West business center boziwan Jinhai rich 402 (A) 21 storey building Applicant before: Saike Pharmaceutical Co., Ltd., Beijing |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SAIKE PHARMACEUTICAL CO., LTD., BEIJING TO: CHINA RESOURCES SAIKE PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160115 Address after: 100028 Beijing City, Chaoyang District Shuguang Sirirath A Phoenix Plaza No. 5 block 27 layer Patentee after: Beijing General Pharmaceutical Corporation Address before: 100021 Beijing city Chaoyang District West business center boziwan Jinhai rich 402 (A) 21 storey building Patentee before: China Resources Saike Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 Termination date: 20210421 |